- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| IRRAS Aktie jetzt für 0€ handeln | |||||
| Mo | ClearPoint Neuro schließt Zustimmungsvereinbarung zur Restrukturierung von IRRAS AB | - | Investing.com Deutsch | ||
| 20.11.25 | ClearPoint Neuro completes acquisition of IRRAS Holdings | 1 | Investing.com | ||
| 20.11.25 | ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS | 638 | ACCESS Newswire | Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire... ► Artikel lesen | |
| 06.11.25 | ClearPoint Neuro to acquire IRRAS Holdings in neurocritical care expansion | 3 | Investing.com | ||
| 06.11.25 | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Agreement to Acquire IRRAS | 391 | ACCESS Newswire | Acquisition Will Further Expand the Potential of ClearPoint Neuro's Drug Delivery Portfolio While Immediately Adding New Indications and Commercial Scale Across a $0.5 Billion Market for the Treatment... ► Artikel lesen |
5 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,790 | +2,00 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| LUMEXA IMAGING | 17,730 | +2,37 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | ||
| SIEMENS HEALTHINEERS | 46,840 | +0,67 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,950 | 0,00 % | Where Alignment Healthcare Stands With Analysts | ||
| BRIGHTSPRING HEALTH SERVICES | 39,080 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| BETA BIONICS | 31,990 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 34,480 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HEARTFLOW | 33,470 | 0,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| PROGYNY | 27,440 | 0,00 % | Progyny-Aktie: Truist Securities stuft auf 'Kaufen' hoch und verweist auf verbesserte Aussichten | ||
| FRESENIUS | 49,650 | -0,20 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| MIMEDX | 6,310 | 0,00 % | MiMedx Group, Inc: MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit-Wound Gel | MARIETTA, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced it has entered into an exclusive agreement with Regen Lab USA LLC to... ► Artikel lesen | |
| NEUROPACE | 16,960 | 0,00 % | BDMD: Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion | NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive... ► Artikel lesen | |
| BILLIONTOONE | 87,59 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,150 | 0,00 % | Privia Health stock rating initiated at Outperform by RBC Capital | ||
| PACS GROUP | 41,365 | 0,00 % | RBC Capital reiterates Outperform rating on PACS Group stock |
IRRAS AB gehört der Branche Gesundheitswesen an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IRRAS AB finden Sie auf Wallstreet Online.